Cornerstone Advisors (Washington)’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
Cornerstone Advisors (Washington)'s CLB Position: Q3 2019 in Review
Cornerstone Advisors (Washington) sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 14 shares — an estimated $1K sold.
Cornerstone Advisors (Washington) first reported a position in CLB in Q2 2014 and held it in 21 quarters. The position peaked at $291K in Q4 2014. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.
- Cornerstone Advisors (Washington) reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
- Cornerstone Advisors (Washington) sold 14 Core Laboratories shares in Q3 2019, an estimated $1K.
- Cornerstone Advisors (Washington) first reported a position in Core Laboratories in Q2 2014 and held it in 21 quarters.
- Cornerstone Advisors (Washington)'s Core Laboratories position peaked at $291K in Q4 2014.
- 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.
Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.